Thematics Asset Management Vertex Pharmaceuticals Inc Transaction History
Thematics Asset Management
- $2.16 Billion
- Q2 2025
A detailed history of Thematics Asset Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Thematics Asset Management holds 10,598 shares of VRTX stock, worth $4.41 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
10,598
Previous 7,956
33.21%
Holding current value
$4.41 Million
Previous $3.86 Million
22.32%
% of portfolio
0.22%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,786Shares Held
236MCall Options Held
1.96MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$12 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.87 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.71 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.9 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $107B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...